货号:GS40825
Zuberitamab is a chimeric monoclonal antibody of the IgG1-kappa isotype that targets the CD20 antigen on the surface of B cells. As an anti-CD20 antibody, it is developed for the treatment of B-cell malignancies, such as non-Hodgkin lymphoma, and certain autoimmune diseases, aiming to deplete pathogenic B cells through immune-mediated mechanisms.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物